{"url":"https://lda.senate.gov/api/v1/filings/7311ebd8-70fa-443a-b0f2-2908d76bf0dc/","filing_uuid":"7311ebd8-70fa-443a-b0f2-2908d76bf0dc","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2025,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/7311ebd8-70fa-443a-b0f2-2908d76bf0dc/print/","filing_document_content_type":"text/html","income":"80000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Brian Pomper","dt_posted":"2025-07-21T12:35:43-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"2001 K St NW","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20006","registrant":{"id":682,"url":"https://lda.senate.gov/api/v1/registrants/682/","house_registrant_id":31784,"name":"AKIN GUMP STRAUSS HAUER & FELD","description":"Law firm","address_1":"2001 K St NW","address_2":null,"address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20006","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"BRIAN POMPER","contact_telephone":"+1 202-887-4000","dt_updated":"2026-07-30T23:00:42.376033-04:00"},"client":{"id":65335,"url":"https://lda.senate.gov/api/v1/clients/65335/","client_id":65335,"name":"CSL BEHRING","general_description":"Biopharmaceutical company","client_government_entity":null,"client_self_select":false,"state":"PA","state_display":"Pennsylvania","country":"US","country_display":"United States of America","ppb_state":"PA","ppb_state_display":"Pennsylvania","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2025-03-01"},"lobbying_activities":[{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Issues related to tariffs; Issues related to direct investment.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":149238,"prefix":null,"prefix_display":null,"first_name":"CARA","nickname":null,"middle_name":null,"last_name":"MORROW","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68995,"prefix":null,"prefix_display":null,"first_name":"ZACHARY","nickname":null,"middle_name":null,"last_name":"RUDISILL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139541,"prefix":"mr","prefix_display":"MR.","first_name":"JOSEPH","nickname":null,"middle_name":"G.","last_name":"FAWKNER","suffix":null,"suffix_display":null},"covered_position":"Senior Policy Advisor for Rep. Carol D. Miller (WV-03), February 2020-January 2022.","new":true}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":198,"name":"Natl Economic Council (NEC)"},{"id":13,"name":"Office of the Vice President of the United States"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}